SCAND3 expression based on
Sample types
Individual cancer stages
Patient's race
Patients's gender
Patient's age
Nodal Metastasis status
TP53 mutation status
KICH : Kidney chromophobe
Comparison Statistical significance Normal-vs-Primary 2.54330000004632E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
KICH : Kidney chromophobe Note
Cancer stage information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.57349999988455E-07
Normal-vs-Stage2
5.94699999999504E-05
Normal-vs-Stage3
4.88809999998896E-06
Normal-vs-Stage4
2.944100E-02
Stage1-vs-Stage2
1.427160E-01
Stage1-vs-Stage3
6.571400E-01
Stage1-vs-Stage4
4.487600E-01
Stage2-vs-Stage3
3.749600E-01
Stage2-vs-Stage4
8.535000E-01
Stage3-vs-Stage4
4.572200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
KICH : Kidney chromophobe Note
Patient race information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.89729999999777E-06
Normal-vs-AfricanAmerican
1.982370E-02
Normal-vs-Asian
7.902400E-01
Caucasian-vs-AfricanAmerican
8.714400E-01
Caucasian-vs-Asian
1.479500E-02
AfricanAmerican-vs-Asian
1.260360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
KICH : Kidney chromophobe Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.51260000003095E-06
Normal-vs-Female
2.34879999999604E-05
Male-vs-Female
3.314400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
KICH : Kidney chromophobe Note
Patient age information is not available for 1 sample and one sample from patient below 21 years not considered in above plot.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.581900E-03
Normal-vs-Age(41-60Yrs)
2.81960000003689E-06
Normal-vs-Age(61-80Yrs)
1.23809999996727E-06
Normal-vs-Age(81-100Yrs)
N/A
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.103800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.248400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
N/A
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.690200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
N/A
Age(61-80Yrs)-vs-Age(81-100Yrs)
N/A
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
KICH : Kidney chromophobe Note
Cancer in nearby lymph nodes cannot be measured (NX) in 21 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.04079999969132E-07
Normal-vs-N1
1.538360E-02
Normal-vs-N2
6.525800E-01
N0-vs-N1
3.638200E-01
N0-vs-N2
4.573400E-01
N1-vs-N2
1.795810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
KICH : Kidney chromophobe Note
Whole exome sequencing data is not available for 1 sample.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.11309999999365E-05
Normal-vs-TP53-NonMutant
1.6929999999693E-06
TP53-Mutant-vs-TP53-NonMutant
3.374800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
